1
![Aevi Genomic Medicine]()
![Aevi Genomic Medicine]()
![Aevi Genomic Medicine]()
Aevi Genomic Medicine
Leadership team
Andrew Pearlman (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care, Life Science
Number of Employees
0 - 50
Headquarters
Wayne, Pennsylvania, United States
Established
2000
Company Registration
SEC CIK number: 0001138776
Traded as
NASDAQ:GNMX
Overview
Location
Summary
Aevi Genomic Medicine (AGM) is a biotechnology company focused on discovering and advancing novel gene therapies to treat serious pediatric diseases with unmet medical needs.
History
AGM was founded in 2016 by Symphony Health, the Morgan Stanley Global Healthcare Investment banking team and a team of seasoned healthcare executives to drive the advancement of gene therapies and cutting-edge medical solutions.
Mission
Our mission is to develop novel life-changing therapies to treat specifically targeted pediatric diseases with significant unmet medical needs.
Vision
Our vision is to develop innovative treatments to provide life-altering solutions for children with serious illnesses.
Key Team
Andrew Pearlman (Founder)
Recognition and Awards
AGM has won several Nanotechnology and Biotech awards, including the 2020 MedTech Breakthrough Awards for best Digital Health Platform and the 2020 Nanotech Breakthrough Awards for Best Nanotech Innovation.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Andrew Pearlman (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care, Life Science
Number of Employees
0 - 50
Headquarters
Wayne, Pennsylvania, United States
Established
2000
Company Registration
SEC CIK number: 0001138776
Traded as
NASDAQ:GNMX